Predictors of long-term survival for patients with pancreatic neuroendocrine neoplasm in FinPanNET: nationwide biobank study with histopathological re-evaluation
: Majala, Susanna; Elonen, Lauri; Kaprio, Tuomas; Vesterinen, Tiina; Kauhanen, Saila; Sammalkorpi, Henna; Parviainen, Helka; Schalin-Jäntti, Camilla; Schildt, Jukka; Laukkarinen, Johanna; Ahola, Reea; Nieminen, Lasse; Rinta-Kiikka, Irina; Ronkainen, Johanna; Sipilä, Kalle; Nortunen, Minna; Karjula, Heikki; Huhta, Heikki; Pohjanen, Vesa-Matti; Mäkinen, Markus; Söderström, Mirvamaaria; Kemppainen, Jukka; Mrena, Johanna; Kuopio, Teijo; Koivula, Anna-Stiina; Rantanen, Tuomo; Pulkkinen, Jukka; Sironen, Reijo; Haglund, Caj; Arola, Johanna; Seppänen, Hanna
Publisher: Oxford University Press (OUP)
: 2025
British Journal of Surgery
: znaf197
: 112
: 10
: 0007-1323
: 1365-2168
DOI: https://doi.org/10.1093/bjs/znaf197
: https://doi.org/10.1093/bjs/znaf197
Pancreatic neuroendocrine tumours (panNETs) comprise a heterogeneous tumour group with unresolved optimal treatment.
: 
This research was funded by the Academy of Finland, the Sigrid Juselius Foundation, the Cancer Foundation Finland, and Finska Läkaresällskapet, and through State Research Funding. 
